DOW:NYSEDow Inc. Analysis
Data as of 2026-05-21 - not real-time
$36.27
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Dow Inc. trades below its 20‑day and 50‑day simple moving averages, while the 200‑day SMA remains well under the current price, signaling a longer‑term bullish bias despite short‑term softness. Technical indicators show a bearish MACD divergence and a decreasing volume trend, suggesting limited upside momentum in the near term. The stock’s RSI sits around 40, indicating it is not yet oversold but also not in the comfort zone of a strong rally. Fundamentally, the company reports negative profit margins, a high debt‑to‑equity ratio above 100%, and a negative free cash flow, which raises concerns about earnings sustainability. However, the dividend yield of roughly 3.9% and a modest payout ratio provide income appeal. Analyst consensus remains positive with a “buy” recommendation and a target price near $43, implying an upside of about 18% from the current level. The broader market sentiment is extremely bullish, reflected by a Fear & Greed index in the “Extreme Greed” zone, which may lift risk‑on stocks like Dow. Yet, geopolitical tension highlighted in recent earnings calls—particularly potential cost spikes from Strait of Hormuz disruptions—adds a layer of uncertainty. Overall, the stock sits at a critical juncture where technical support, dividend attractiveness, and analyst optimism contend with weak earnings and balance‑sheet strain. Investors should weigh the income benefits against the earnings volatility and debt burden when deciding on positioning.
In the short run, caution is advised due to bearish MACD and waning volume, while the medium horizon offers upside potential if the company can stabilize cash flows and navigate cost pressures. Long‑term outlook hinges on the firm’s ability to improve profitability and reduce leverage, making a dividend‑focused hold more appropriate than a growth‑oriented bet.
In the short run, caution is advised due to bearish MACD and waning volume, while the medium horizon offers upside potential if the company can stabilize cash flows and navigate cost pressures. Long‑term outlook hinges on the firm’s ability to improve profitability and reduce leverage, making a dividend‑focused hold more appropriate than a growth‑oriented bet.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering near technical support
- Bearish MACD divergence
- Decreasing trading volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst target price indicating ~18% upside
- Attractive dividend yield
- Bullish long‑term trend indicated by SMA alignment
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High debt load and negative earnings
- Sustainable dividend income
- Uncertainty around cost inflation from geopolitical risks
Key Metrics & Analysis
Financial Health
Revenue Growth-6.10%
Profit Margin-7.24%
P/E Ratio17.0
ROE-15.26%
ROA-0.14%
Debt/Equity117.13
P/B Ratio1.7
Op. Cash Flow$2.1B
Free Cash Flow$-675875008
Technical Analysis
TrendBullish
RSI40.0
Support$35.92
Resistance$41.47
MA 20$38.74
MA 50$38.68
MA 200$28.55
MACDBearish
VolumeDecreasing
Fear & Greed Index89.89
Valuation
Fair Value$4.50
Target Price$43.06
Upside/Downside18.73%
GradeFair
TypeValue
Dividend Yield3.86%
Risk Assessment
Beta0.56
Volatility52.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.